Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH(1–31)NH2] in postmenopausal women with osteoporosis
2015 ◽
Vol 100
(2)
◽
pp. 697-706
◽
2013 ◽
Vol 52
(11)
◽
pp. 995-1004
◽
2003 ◽
Vol 18
(3)
◽
pp. 539-543
◽
2002 ◽
Vol 17
(7)
◽
pp. 1151-1161
◽
2007 ◽
Vol 146
(5)
◽
pp. 326
◽